TF
AVNS

Tompkins Financial’s Avanos Medical AVNS Stock Holding History

Tompkins Financial’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-2
Closed -$22 – 573
2025
Q4 		$22 Buy
+2
New +$23 ﹤0.01% 636
2017
Q1 		– Sell
-23
Closed -$1K – 364
2016
Q4 		$1K Hold
23
– – ﹤0.01% 364
2016
Q3 		$1K Sell
23
-34
-60% -$1.19K ﹤0.01% 373
2016
Q2 		$2K Sell
57
-45
-44% -$1.38K ﹤0.01% 493
2016
Q1 		$3K Hold
102
– – ﹤0.01% 449
2015
Q4 		$3K Hold
102
– – ﹤0.01% 479
2015
Q3 		$3K Sell
102
-2
-2% -$70 ﹤0.01% 473
2015
Q2 		$4K Hold
104
– – ﹤0.01% 468
2015
Q1 		$5K Sell
104
-84
-45% -$3.89K ﹤0.01% 467
2014
Q4 		$9K Buy
+188
New +$7.39K ﹤0.01% 387

Other funds holding AVNS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return

Tompkins Financial's AVNS Position: Q1 2026 in Review

Tompkins Financial sold out of Avanos Medical (AVNS) in Q1 2026, closing a stake of 2 shares — an estimated $22 sold.

Tompkins Financial first reported a position in AVNS in Q4 2014 and held it in 10 quarters. The position peaked at $9K in Q4 2014. 257 funds tracked by Wall St. Rank hold AVNS as of Q1 2026.

  • Tompkins Financial reported no remaining Avanos Medical position as of Q1 2026 after selling out during the quarter.
  • Tompkins Financial sold 2 Avanos Medical shares in Q1 2026, an estimated $22.
  • Tompkins Financial first reported a position in Avanos Medical in Q4 2014 and held it in 10 quarters.
  • Tompkins Financial's Avanos Medical position peaked at $9K in Q4 2014.
  • 257 funds tracked by Wall St. Rank held Avanos Medical as of Q1 2026.

Based on Tompkins Financial's 13F filing for Q1 2026, filed 9 Apr 2026.